ALICAPASE – Capivasertib

Capivasertib is listed in the VetinoPharma B2B pharmaceutical product catalog under Oncology. It is commonly referenced in treatment areas related to hormone receptor-positive her2-negative breast cancer reference in selected biomarker contexts and should be reviewed for the relevant market, documentation, and intended business context. For wholesale, distribution, or sourcing inquiries, please contact the VetinoPharma team.